20.08.2012 • News

Bayer Sues Warner Chilcott for Patent Infringement

Warner Chilcott said German drugmaker Bayer filed a complaint against the U.S. pharmaceutical company, alleging that Warner's oral contraceptive drug Lo Loestrin FE infringes a Bayer patent. According to the complaint filed in a U.S. district court, Bayer is seeking an injunction on the product along with unspecified monetary damages, Warner said in a filing. New Jersey-based Warner said it would defend the litigation as it believes the complaint lacks merit.

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

From Lab to Market Challenge

Vote Now: Germany's Most Promising Chemistry Start-ups
Choose your favourite among the finalists

Vote Now: Germany's Most Promising Chemistry Start-ups

The "From Lab to Market Challenge" brings together the most promising founders from chemistry, materials science, and industrial biotechnology. Starting June 1st, you can cast your public vote for the finalists on CHEManager.com — before the award ceremony with €10,000 in prizes takes place on June 25th.

most read

Photo

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.